Galderma Group AG (GALDY) Dividends

Galderma Group AG engages in the provision of science-based premium dermatology solutions. The company is headquartered in Zug, Zug. The company went IPO on 2024-03-22. The Company, through its subsidiaries, operates a portfolio of various self-care brands focusing primarily on dermatological solutions, through its subsidiaries. Products within the portfolio include neuromodulators, fillers, and biostimulators. These products are designed to relax wrinkles via injection, fill wrinkles in a specific location via injection, and stimulate the body's cells to function optimally. The production process for the various products primarily takes place in-house, from research and development to manufacturing. In addition, services including education, scientific engagements, and other services are offered.